Gapping up
In reaction to strong earnings/guidance: DSCI +16.5%, BLK +4.6%, PNC +2.7%, KMP +1.8%, BBT +0.2%, GS +0.4%, PLXS +0.1% (ticking higher).
M&A news: CEC +11.8% (agrees to be acquired by an affiliate of Apollo Global Management (APO) for $54.00 per share in cash ), JNJ +1.6% (Johnson & Johnson receives binding offer from The Carlyle Group (CG) to acquire its Ortho-Clinical Diagnostics business for $4.15 bln), TWC +1% ( Charter and Comcast are in renewed discussions concerning joint bid for TWC).
Select metals/mining stocks trading higher: RIO+3.4% (reports record quarterly and annual iron ore production, shipments and rail volumes), BBL +3.3%, VALE +2.2%, BHP +2.1% (upgraded to Buy from Neutral at Citigroup ), MT +1.2%.
Select shipping related names showing strength: GNK +4.9%, FREE +4.8%, NAT +3.7%, FRO +2.1%, DRYS +1%.
Solar names are trading higher: CSIQ +4.8%, FSLR +4.6%, SCTY +4.7% (initiated with a Buy at Deutsche Bank), RSOL +3.7%, SOL +3%, SPWR +2.9% (initiated with an Overweight at JPMorgan), JASO +2.9%, JKS +2% ( prices upsized offering of 3.75 mln ADSs, each representing four ordinary shares of the co, at $35.25 per ADS), YGE +2%, TSL +1.4%,
Other news: ZOOM +54.7% (entered a non-binding LoI with Tinho Union Holding), SRPT +14.1% (announces Eteplirsen demonstrates continued stability on Walking Test through 120 weeks in Phase IIb study in Duchenne Muscular Dystrophy), TXTR +8.6% ( SAC Capital Advisors discloses 5.0% passive stake in 13G filing), AMCC +5.5% (following mention on Fast Money last night regarding options activity ), ILMN +4.9% (Illumina and Amgen enter agreement to develop oncology companion diagnostic test), PLUG +4.2% (seeing continued strength; will host conference call to discuss Jan business update today at 10am ET; continues to expect first quarter 2014 booking to exceed the past quarter), PSTI +3% (may be attributed to positive blog mention), KNDI +2.7% (continued strength), MRK +0.5% (attributed to FDA panel vote in favor of Vorapaxar approval), TRBAA +0.4% (modestly rebounding from Aereo concern weakness; also Aereo ruling far from definitive - Oppenheimer).
Analyst comments: ELX +4.7% (upgraded to Buy from Neutral at BofA/Merrill), HPQ +4% (upgraded to Buy from Neutral at BofA/Merrill), VMW +1.9% (upgraded to Buy from Neutral at Citigroup), FEYE +1.6% (initiated with an Outperform at William Blair), NUVA +1.5% (upgraded to Neutral from Sell at Goldman), MU +1% (Micron upgraded to Outperform from Market Perform at JMPSecurities)
M&A news: CEC +11.8% (agrees to be acquired by an affiliate of Apollo Global Management (APO) for $54.00 per share in cash ), JNJ +1.6% (Johnson & Johnson receives binding offer from The Carlyle Group (CG) to acquire its Ortho-Clinical Diagnostics business for $4.15 bln), TWC +1% ( Charter and Comcast are in renewed discussions concerning joint bid for TWC).
Select metals/mining stocks trading higher: RIO+3.4% (reports record quarterly and annual iron ore production, shipments and rail volumes), BBL +3.3%, VALE +2.2%, BHP +2.1% (upgraded to Buy from Neutral at Citigroup ), MT +1.2%.
Select shipping related names showing strength: GNK +4.9%, FREE +4.8%, NAT +3.7%, FRO +2.1%, DRYS +1%.
Solar names are trading higher: CSIQ +4.8%, FSLR +4.6%, SCTY +4.7% (initiated with a Buy at Deutsche Bank), RSOL +3.7%, SOL +3%, SPWR +2.9% (initiated with an Overweight at JPMorgan), JASO +2.9%, JKS +2% ( prices upsized offering of 3.75 mln ADSs, each representing four ordinary shares of the co, at $35.25 per ADS), YGE +2%, TSL +1.4%,
Other news: ZOOM +54.7% (entered a non-binding LoI with Tinho Union Holding), SRPT +14.1% (announces Eteplirsen demonstrates continued stability on Walking Test through 120 weeks in Phase IIb study in Duchenne Muscular Dystrophy), TXTR +8.6% ( SAC Capital Advisors discloses 5.0% passive stake in 13G filing), AMCC +5.5% (following mention on Fast Money last night regarding options activity ), ILMN +4.9% (Illumina and Amgen enter agreement to develop oncology companion diagnostic test), PLUG +4.2% (seeing continued strength; will host conference call to discuss Jan business update today at 10am ET; continues to expect first quarter 2014 booking to exceed the past quarter), PSTI +3% (may be attributed to positive blog mention), KNDI +2.7% (continued strength), MRK +0.5% (attributed to FDA panel vote in favor of Vorapaxar approval), TRBAA +0.4% (modestly rebounding from Aereo concern weakness; also Aereo ruling far from definitive - Oppenheimer).
Analyst comments: ELX +4.7% (upgraded to Buy from Neutral at BofA/Merrill), HPQ +4% (upgraded to Buy from Neutral at BofA/Merrill), VMW +1.9% (upgraded to Buy from Neutral at Citigroup), FEYE +1.6% (initiated with an Outperform at William Blair), NUVA +1.5% (upgraded to Neutral from Sell at Goldman), MU +1% (Micron upgraded to Outperform from Market Perform at JMPSecurities)